Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$281K Sell
89,550
-7,200
-7% -$22.5K 0.02% 249
2026
Q1
$283K Sell
96,750
-12,380
-11% -$35.4K 0.03% 227
2025
Q4
$270K Hold
109,130
0.03% 238
2025
Q3
$243K Sell
109,130
-6,000
-5% -$13.7K 0.02% 250
2025
Q2
$277K Hold
115,130
0.03% 223
2025
Q1
$268K Buy
115,130
+2,230
+2% +$4.46K 0.03% 208
2024
Q4
$209K Buy
112,900
+900
+0.8% +$1.99K 0.02% 235
2024
Q3
$273K Buy
112,000
+46,300
+70% +$104K 0.03% 216
2024
Q2
$135K Buy
+65,700
New +$150K 0.02% 278

Other funds holding ABEV

BFSG LLC's ABEV Position: Q2 2026 in Review

BFSG LLC reduced its Ambev (ABEV) stake by 7.4% in Q2 2026, selling an estimated $22.5K and leaving 89,550 shares worth $281K. The position accounts for 0.02% of the portfolio, ranked #249.

BFSG LLC first reported a position in ABEV in Q2 2024 and has held it in 9 quarters since. The position peaked at $283K in Q1 2026. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • BFSG LLC held 89,550 shares of Ambev worth $281K as of Q2 2026.
  • BFSG LLC sold 7,200 Ambev shares in Q2 2026, an estimated $22.5K.
  • Ambev made up 0.02% of BFSG LLC's portfolio in Q2 2026, its #249 holding.
  • BFSG LLC first reported a position in Ambev in Q2 2024 and has held it in 9 quarters since.
  • BFSG LLC's Ambev position peaked at $283K in Q1 2026.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.